ROIVANT SCIENCES LTD. Deferred Tax Assets, Operating Loss Carryforwards
ROIVANT SCIENCES LTD. (ROIV) had Deferred Tax Assets, Operating Loss Carryforwards of $550.01 million as of 2026-03-31, per its 10-K filed 2026-05-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-05-20
- 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards $550.01M.
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards $469.34M.
- 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards $359.97M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $519.05M.
- 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards $422.61M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-03-31 | $550.01M 10-K · filed 2026-05-20 | |
| 2025-03-31 | $469.34M 10-K · filed 2026-05-20 | |
| 2024-03-31 | $359.97M 10-K · filed 2025-05-29 | $519.05M 10-K · filed 2024-05-30 |
| 2023-03-31 | $422.61M 10-K · filed 2024-05-30 | |
| 2022-03-31 | $312.75M 10-K · filed 2023-06-28 | |
| 2021-03-31 | $202.91M 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |